O-20 Phase I/IB study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer
R. Kim, Iman Imanirad, Estrella M. Carballido, Jonathan Strosberg, Y. Kim, D. Kim
Topics & Concepts
RegorafenibMedicineNivolumabKRASColorectal cancerInternal medicineOncologyNeuroblastoma RAS viral oncogene homologCohortRefractory (planetary science)Clinical endpointCancerClinical trialImmunotherapyAstrobiologyPhysicsCancer Immunotherapy and BiomarkersInflammatory mediators and NSAID effectsColorectal Cancer Treatments and Studies